GLP-1 Resource Center

Why can I not sleep on GLP-1 medications?

Sleep disruption on GLP-1 medications is commonly reported and rarely discussed in advance. Patients describe a recognisable pattern: exhausted during the day, unable to fall asleep at night, waking frequently, never feeling rested. Why it happens is not fully established, but there are plausible physiological explanations worth understanding.

A proposed mechanism: tryptophan

The body produces serotonin from tryptophan, an amino acid obtained through dietary protein. When food intake drops significantly, and a 2025 joint advisory from four professional societies (Mozaffarian et al., Obesity) reported reductions in caloric intake of 16 to 39 percent across the GLP-1 drug class, tryptophan intake may drop with it. Because serotonin is involved in sleep onset, this is a proposed explanation for why falling asleep becomes harder. It is plausible and mechanistically grounded, but it has not been demonstrated in GLP-1 users, and we say so. A similar mechanism is discussed for mood changes on GLP-1 medications.

A second proposed contributor: the demands of rapid change

Rapid weight loss places real demands on the body, and some researchers discuss stress physiology, including cortisol, as a contributor to feeling alert at night when you should be winding down. Changed eating patterns and smaller evening meals are also discussed. None of these has been isolated as the cause in GLP-1 weight loss specifically. Most likely several factors overlap.

The distinction from fatigue

GLP-1 sleep disruption and GLP-1 fatigue are related but different problems that often co-occur. Fatigue is primarily discussed in terms of nutritional intake and cellular energy. Sleep disruption is about what happens at night. Attending to one does not automatically resolve the other.

What is reasonable to attend to

Eating enough, and enough protein, is the practical foundation, since tryptophan comes from food, and a diet that is short on protein is short on the raw material serotonin is made from. If overall intake is down, closing that gap with a serving of TAKE Nourish, which provides 20 to 21g of plant protein, is a reasonable, low-risk step. This is nutritional reasoning, not a tested sleep intervention. It has not been studied in GLP-1 users specifically, and taking Nourish is not going to resolve sleep disruption on its own. Micronutrient intake during GLP-1 treatment is worth understanding for the same reason.

One thing worth stating plainly rather than implying: TAKE Complete contains 50mg of magnesium, a nutrient sometimes studied for sleep at doses several times higher. At Complete's dose, that is nutritional support for a documented shortfall during reduced intake, not a sleep dose, and we are not going to suggest it is one.

None of this is a treatment for sleep disruption, and we are not going to present it as one. TAKE does not currently make a sleep-specific product; if sleep disruption is significant or persistent, that is a conversation for your prescriber rather than something to solve with a supplement.

These statements have not been evaluated by the Food and Drug Administration. TAKE products are not intended to diagnose, treat, cure, or prevent any disease. Individual results vary. Always speak with your healthcare provider about medication side effects or medical concerns.